EOMES, eomesodermin, 8320

N. diseases: 60; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007102
Disease: Malignant tumor of colon
Malignant tumor of colon
0.310 Biomarker disease CTD_human In human colon cancer cells, forced overexpression of Eomes enhanced cell viability and protected against staurosporine-induced apoptosis. 27539959 2016
CUI: C0007102
Disease: Malignant tumor of colon
Malignant tumor of colon
0.310 AlteredExpression disease BEFREE We screened a panel of human primary colon cancers and patient-matched controls (n = 30) and detected Eomes overexpression at the mRNA and protein level. 27539959 2016
Malignant neoplasm of urinary bladder
0.310 Biomarker disease CTD_human Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer. 26039340 2015
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.310 Biomarker disease CTD_human Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer. 26039340 2015
Malignant neoplasm of urinary bladder
0.310 AlteredExpression disease BEFREE Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation. 23056278 2012
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.310 AlteredExpression disease BEFREE Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation. 23056278 2012
Gastro-enteropancreatic neuroendocrine tumor
0.300 Biomarker disease CTD_human A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors. 29915428 2018
CUI: C0009375
Disease: Colonic Neoplasms
Colonic Neoplasms
0.300 Biomarker group CTD_human Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer. 27539959 2016
Autoimmune Diseases of the Nervous System
0.300 Biomarker group CTD_human Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes. 27742544 2016
CUI: C0751872
Disease: Immune Disorders, Nervous System
Immune Disorders, Nervous System
0.300 Biomarker disease CTD_human Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes. 27742544 2016
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.300 Biomarker group CTD_human Ablation of hippocampal neurogenesis in mice impairs the response to stress during the dark cycle. 26415720 2015
CUI: C0376280
Disease: Anxiety States, Neurotic
Anxiety States, Neurotic
0.300 Biomarker disease CTD_human Ablation of hippocampal neurogenesis in mice impairs the response to stress during the dark cycle. 26415720 2015
CUI: C1279420
Disease: Anxiety neurosis (finding)
Anxiety neurosis (finding)
0.300 Biomarker disease CTD_human Ablation of hippocampal neurogenesis in mice impairs the response to stress during the dark cycle. 26415720 2015
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.300 GeneticVariation disease UNIPROT
CUI: C0175754
Disease: Agenesis of corpus callosum
Agenesis of corpus callosum
0.100 Biomarker disease HPO
CUI: C0239998
Disease: Recurrent infections
Recurrent infections
0.100 Biomarker phenotype HPO
CUI: C0266464
Disease: Polymicrogyria
Polymicrogyria
0.100 Biomarker disease HPO
CUI: C0266470
Disease: Cerebellar Hypoplasia
Cerebellar Hypoplasia
0.100 Biomarker disease HPO
CUI: C0476273
Disease: Respiratory distress
Respiratory distress
0.100 Biomarker phenotype HPO
CUI: C1531647
Disease: Cerebral ventriculomegaly
Cerebral ventriculomegaly
0.100 Biomarker phenotype HPO
CUI: C2677180
Disease: Congenital microcephaly
Congenital microcephaly
0.100 Biomarker disease HPO
CUI: C3278923
Disease: Dilated ventricles (finding)
Dilated ventricles (finding)
0.100 Biomarker phenotype HPO
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.070 AlteredExpression group BEFREE Using an adoptive transfer model of cancer immunotherapy, we demonstrate that constitutive eomesodermin (Eomes) expression in tumor-specific CD8 T cells improves tumor rejection and survival. 29271784 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.070 AlteredExpression group BEFREE Moreover, we observed that generation of superior TCM cells in NLGP treated surgically removed tumor hosts is related to the activation of Wnt signalling in memory CD8<sup>+</sup> T cells with concomitant inhibition of GSK-3β and stabilisation of β-catenin, which ultimately activates transcription of Wnt target genes, like, eomesodermin, a signature molecule of CD8<sup>+</sup> TCM cells. 28684164 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.070 Biomarker group BEFREE We conclude from the current investigation, and prior literature, that Eomes has a divergent role in cancer development, with evidence for tumor suppressor and oncogenic functions, depending on stage and tissue context. 27539959 2016